BRIC Animal Vaccines Market

In this report, the animal/veterinary vaccines market is divided into three geographies, namely, Brazil, China, and India. These markets are further divided into products, animal diseases, and technology.

The major drivers for the growth of this market are increasing investment opportunities, large population of companion and livestock animals, growing prevalence of animal diseases, awareness about animal diseases among farmers, increasing government initiatives, and rising incidences of zoonotic diseases. However, the growing storage cost for vaccines, and increasing consumption of vegetarian food in major economies (owing to increasing risk of obesity and other chronic disorders related to excessive meat consumption) are the major factors restraining the growth of this market.

In emerging economies such as Brazil, China, and India, the increasing meat demand and growing awareness about animal health are expected to provide significant investment opportunities for major stakeholders in the animal/veterinary vaccines market. In addition, technological innovations like the development of DNA vaccines are further expected to offer high growth opportunities for market players in the coming years.

The major players operating in the Brazilian animal/veterinary vaccines market include Merial (France), Biomanguinhos/Fiocruz (Brazil), Butantan Institute (Brazil), Tecpar (Brazil), OuroFino (Brazil), Vallée (Brazil), Elanco (U.S.), and Eurofarma – Pearson/Allvet (Brazil).

The major players in the animal/veterinary vaccines market in China include Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), Ceva (France), and Ringpu Bio-Technology Merck (U.S.). Furthermore, local players involved in this market include Chengdu Huasun (China), Jinyu Group (China), Tecon Animal Husbandry Bio-Technology Co. Ltd. (China), Tech-Bank (China), Zhejiang Shenghua Biok Chemical Company Limited (China), Dahuanong (China), Liaoning Yikang Biology Co Ltd (China), and Wuhan Chopper Biology Co. Ltd. (China).

The Indian animal/veterinary vaccines market is expected to witness a double-digit growth rate during in the forecast period. The leading players in the Indian animal/veterinary vaccines market are Indian Immunologicals (India), Indovax (India), Biovet (Europe), Hester Biosciences (India), Brilliant Bio Pharma (India), MSD Animal Health (Merck) (India),), and Veterinary Biologicals (India). Local players such as Serum Institute of India, Shantha Biotechnics (India), Bharat Biotech (India), Panacea Biotech (India), and Bio-Med (India) are also playing a major role in the market.